| Carbaglu 200 mg dispersible tablets EU/1/02/246/1-2 |
Carglumic acid |
Recordati Rare Diseases |
— |
| Carbamazepine 100 mg Tablets PA22871/010/001 |
Carbamazepine |
Azure Pharmaceuticals Ltd. |
Not marketed |
| Carbamazepine 200 mg Tablets PA22871/010/002 |
Carbamazepine |
Azure Pharmaceuticals Ltd. |
Not marketed |
| Carbamazepine 400 mg Tablets PA22871/010/003 |
Carbamazepine |
Azure Pharmaceuticals Ltd. |
Not marketed |
| Carbimazole 20 mg Tablets PA22865/006/002 |
Carbimazole |
Renata Pharmaceuticals (Ireland) Limited |
Marketed |
| Carbimazole 5 mg Tablets PA22865/006/001 |
Carbimazole |
Renata Pharmaceuticals (Ireland) Limited |
Marketed |
| Carbomix 50 g Granules for Oral Suspension PA1418/007/001 |
Charcoal, activated |
Athlone Pharmaceuticals Limited |
Marketed |
| Carboplatin 10 mg/ml concentrate for solution for infusion PA2059/032/001 |
Carboplatin |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Carbosan 2% w/w Gel PA0074/011/001 |
CARBENOXOLONE SODIUM |
Rowa Pharmaceuticals Limited |
Marketed |
| Carmustine medac 100 mg powder and solvent for concentrate for solution for infusion EU/1/18/1278/001 |
Carmustine |
medac Gesellschaft für klinische Spezialpräparate mbH |
— |
| CARVYKTI 3.2 × 10^6 – 1 × 10^8 cells dispersion for infusion EU/1/22/1648/001 |
Ciltacabtagene autoleucel |
Janssen Pharmaceutica NV |
— |
| Casgevy 4 - 13 × 10^6 cells/mL dispersion for infusion EU/1/23/1787/001 |
Exagamglogene autotemcel |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Casodex 50 mg film-coated tablets PA23154/002/001 |
Bicalutamide |
Laboratoires Juvise Pharmaceuticals |
Marketed |
| Caspofungin Accord EU/1/15/1081/001 |
Caspofungin acetate |
Accord Healthcare S.L.U. |
— |
| Caspofungin Accord EU/1/15/1081/002 |
Caspofungin acetate |
Accord Healthcare S.L.U. |
— |
| Catiolanze 50 micrograms/mL eye drops, emulsion EU/1/23/1763/001-004 |
Latanoprost |
Santen OY |
— |
| Cayston 75 mg powder and solvent for nebuliser solution. EU/1/09/543/001 |
Aztreonam |
Gilead Sciences Ireland UC |
— |
| Cefixime 200 mg film-coated tablets PA1335/002/001 |
CEFIXIME TRIHYDRATE |
Orchid Europe Limited |
Not marketed |
| Cefuroxime 1.5 g powder for solution for injection/infusion PA2059/006/002 |
Cefuroxime Sodium |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Cefuroxime 750 mg powder for solution for injection/infusion PA2059/006/001 |
Cefuroxime Sodium |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Cegfila 6 mg solution for injection in pre-filled syringe EU/1/19/1409/001 |
Pegfilgrastim |
Mundipharma Corporation (Ireland) Limited |
— |
| Cejemly 600 mg concentrate for solution for infusion EU/1/24/1833/001 |
Sugemalimab |
Cstone Pharmaceuticals Ireland Limited |
— |
| CellCept 1 g/5 ml Powder for oral suspension EU/1/96/005/006 |
Mycophenolate mofetil |
Roche Registration GmbH |
— |
| CellCept 250 mg Capsule, hard EU/1/96/005/001 |
Mycophenolate mofetil |
Roche Registration GmbH |
— |
| CellCept 250 mg Capsule, hard EU/1/96/005/003 |
Mycophenolate mofetil |
Roche Registration GmbH |
— |
| CellCept 500 mg Film-coated tablet EU/1/96/005/002 |
Mycophenolate mofetil |
Roche Registration GmbH |
— |
| CellCept 500 mg Film-coated tablet EU/1/96/005/004 |
Mycophenolate mofetil |
Roche Registration GmbH |
— |
| CellCept 500 mg Powder for concentrate for solution for infusion EU/1/96/005/005 |
Mycophenolate mofetil |
Roche Registration GmbH |
— |
| Celldemic suspension for injection in pre-filled syringe Zoonotic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures). EU/1/24/1806/001 |
Influenza virus A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 strain, HA surface antigen |
Seqirus Netherlands B.V. |
— |
| Celsentri 150 mg Film-coated tablet EU/1/07/418/1-5 |
Maraviroc |
ViiV Healthcare BV |
— |
| Celsentri 20mg/ ml oral solution EU/01/07/418/013 |
Maraviroc |
ViiV Healthcare BV |
— |
| Celsentri 25 mg Film-coated tablet EU/1/07/418/011 |
Maraviroc |
ViiV Healthcare BV |
— |
| Celsentri 300 mg Film-coated tablet EU/1/07/418/6-10 |
Maraviroc |
ViiV Healthcare BV |
— |
| Celsentri 75 mg Film-coated tablet EU/1/07/418/012 |
Maraviroc |
ViiV Healthcare BV |
— |
| Celsunax 74 MBq/mL solution for injection EU/1/21/1560/001-002 |
Ioflupane (123I) |
Pinax Pharma GmbH |
— |
| Ceplene 0.5 mg/0.5 ml solution for injection EU/1/08/477/1 |
Histamine dihydrochloride |
Laboratoires DELBERT |
— |
| Ceprotin EU/1/01/190/001 |
Protein c |
Baxter Vaccine AG |
— |
| Ceprotin EU/1/01/190/002 |
Protein c |
Baxter Vaccine AG |
— |
| Cerdelga 21mg Hard capsule EU/1/14/974/004 |
Eliglustat tartrate |
Sanofi B.V. |
— |
| Cerdelga 84mg Hard capsule EU/1/14/974/001-002 |
Eliglustat (as tartrate) |
Sanofi B.V. |
— |
| Cerezyme 400 Units Powder for concentrate for solution for infusion EU/1/97/053/003 |
Imiglucerase |
Sanofi B.V. |
— |
| Cerezyme 400 Units Powder for concentrate for solution for infusion EU/1/97/053/004 |
Imiglucerase |
Sanofi B.V. |
— |
| Cerezyme 400 Units Powder for concentrate for solution for infusion EU/1/97/053/005 |
Imiglucerase |
Sanofi B.V. |
— |
| Cervarix suspension for injection Human Papillomavirus vaccine [Types 16, 18] (Recombinant, adjuvanted, adsorbed) EU/1/07/419/1-12 |
Hpv 16 l1 protein, Hpv 18 l1 protein |
GlaxoSmithKline Biologicals S.A. |
— |
| Cetrotide 0.25 mg powder and solvent for solution for injection EU/1/99/100/001 |
Cetrorelix acetate |
Merck Europe B.V. |
— |
| Cetrotide 0.25 mg powder and solvent for solution for injection EU/1/99/100/002 |
Cetrorelix acetate |
Merck Europe B.V. |
— |
| CEVENFACTA 1 mg (45 KIU) powder and solvent for solution for injection EU/1/22/1664/001 |
Eptacog beta (activated) |
Laboratoire francais du Fractionnement et des Biotechnolgies |
— |
| CEVENFACTA 2 mg (90 KIU) powder and solvent for solution for injection EU/1/22/1664/002 |
Eptacog beta (activated) |
Laboratoire francais du Fractionnement et des Biotechnolgies |
— |
| CEVENFACTA 5 mg (225 KIU) powder and solvent for solution for injection EU/1/22/1664/003 |
Eptacog beta (activated) |
Laboratoire francais du Fractionnement et des Biotechnolgies |
— |
| Ceziboe 0.25 mg solution for injection in pre-filled syringe PA2050/005/001 |
Cetrorelix |
Sun Pharmaceutical Industries Europe B.V. |
Not marketed |